Product
MVA Smallpox Vaccine
1 clinical trial
2 indications
Indication
Yellow feverIndication
Yellow Fever VaccinationClinical trial
A Phase I, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA 720 Adjuvant in 18-45 Year Old Healthy AdultsStatus: Completed, Estimated PCD: 2018-03-22